| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 7.47e-06 | 303 | 48 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 5.24e-05 | 562 | 48 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 1.57e-04 | 8 | 48 | 2 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 2.52e-04 | 10 | 48 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 1.05e-03 | 20 | 48 | 2 | GO:0042800 | |
| GeneOntologyBiologicalProcess | mRNA processing | 5.14e-06 | 551 | 49 | 9 | GO:0006397 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MED15 BCL9L CASC3 KMT2D SETD1B PRPF40B UBAP2L SMARCC1 KDM6B SF3A2 CPSF7 | 2.28e-04 | 1377 | 48 | 11 | GO:0140513 |
| GeneOntologyCellularComponent | SCAR complex | 3.36e-04 | 12 | 48 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | MLL3/4 complex | 3.36e-04 | 12 | 48 | 2 | GO:0044666 | |
| GeneOntologyCellularComponent | nuclear speck | 4.38e-04 | 431 | 48 | 6 | GO:0016607 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 4.98e-04 | 287 | 48 | 5 | GO:0035770 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 6.83e-04 | 75 | 48 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | U2-type prespliceosome | 7.72e-04 | 18 | 48 | 2 | GO:0071004 | |
| GeneOntologyCellularComponent | prespliceosome | 7.72e-04 | 18 | 48 | 2 | GO:0071010 | |
| GeneOntologyCellularComponent | nuclear body | 9.55e-04 | 903 | 48 | 8 | GO:0016604 | |
| GeneOntologyCellularComponent | U2-type spliceosomal complex | 1.44e-03 | 97 | 48 | 3 | GO:0005684 | |
| GeneOntologyCellularComponent | methyltransferase complex | 1.96e-03 | 108 | 48 | 3 | GO:0034708 | |
| GeneOntologyCellularComponent | Sm-like protein family complex | 2.58e-03 | 119 | 48 | 3 | GO:0120114 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 3.35e-03 | 269 | 48 | 4 | GO:0036464 | |
| GeneOntologyCellularComponent | actin-based cell projection | 3.76e-03 | 278 | 48 | 4 | GO:0098858 | |
| Domain | RRM | 1.87e-05 | 217 | 48 | 6 | SM00360 | |
| Domain | RRM_dom | 2.42e-05 | 227 | 48 | 6 | IPR000504 | |
| Domain | RRM | 2.60e-05 | 230 | 48 | 6 | PS50102 | |
| Domain | - | 3.62e-05 | 244 | 48 | 6 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 4.95e-05 | 258 | 48 | 6 | IPR012677 | |
| Domain | ZnF_U1 | 5.55e-05 | 29 | 48 | 3 | SM00451 | |
| Domain | Znf_U1 | 5.55e-05 | 29 | 48 | 3 | IPR003604 | |
| Domain | FF | 9.64e-05 | 6 | 48 | 2 | PF01846 | |
| Domain | FF | 9.64e-05 | 6 | 48 | 2 | SM00441 | |
| Domain | FF | 9.64e-05 | 6 | 48 | 2 | PS51676 | |
| Domain | FF_domain | 9.64e-05 | 6 | 48 | 2 | IPR002713 | |
| Domain | RNA_pol_II-bd | 1.35e-04 | 7 | 48 | 2 | IPR006903 | |
| Domain | CTD_bind | 1.35e-04 | 7 | 48 | 2 | PF04818 | |
| Domain | RPR | 1.79e-04 | 8 | 48 | 2 | SM00582 | |
| Domain | CID_dom | 1.79e-04 | 8 | 48 | 2 | IPR006569 | |
| Domain | CID | 1.79e-04 | 8 | 48 | 2 | PS51391 | |
| Domain | RRM_1 | 1.89e-04 | 208 | 48 | 5 | PF00076 | |
| Domain | WW | 2.39e-04 | 47 | 48 | 3 | PF00397 | |
| Domain | WW | 2.54e-04 | 48 | 48 | 3 | SM00456 | |
| Domain | WW_DOMAIN_2 | 3.04e-04 | 51 | 48 | 3 | PS50020 | |
| Domain | WW_DOMAIN_1 | 3.04e-04 | 51 | 48 | 3 | PS01159 | |
| Domain | WW_dom | 3.22e-04 | 52 | 48 | 3 | IPR001202 | |
| Domain | Znf_C2H2_matrin | 4.20e-04 | 12 | 48 | 2 | IPR000690 | |
| Domain | WH2 | 5.77e-04 | 14 | 48 | 2 | SM00246 | |
| Domain | Post-SET_dom | 7.58e-04 | 16 | 48 | 2 | IPR003616 | |
| Domain | WH2 | 7.58e-04 | 16 | 48 | 2 | PF02205 | |
| Domain | PostSET | 7.58e-04 | 16 | 48 | 2 | SM00508 | |
| Domain | POST_SET | 7.58e-04 | 16 | 48 | 2 | PS50868 | |
| Domain | ZF_MATRIN | 9.64e-04 | 18 | 48 | 2 | PS50171 | |
| Domain | WH2_dom | 1.32e-03 | 21 | 48 | 2 | IPR003124 | |
| Domain | WH2 | 1.72e-03 | 24 | 48 | 2 | PS51082 | |
| Domain | - | 2.02e-03 | 26 | 48 | 2 | 1.25.40.90 | |
| Domain | ENTH_VHS | 2.51e-03 | 29 | 48 | 2 | IPR008942 | |
| Domain | SET | 4.98e-03 | 41 | 48 | 2 | PF00856 | |
| Domain | SET | 6.23e-03 | 46 | 48 | 2 | SM00317 | |
| Domain | SET_dom | 7.32e-03 | 50 | 48 | 2 | IPR001214 | |
| Domain | SET | 7.32e-03 | 50 | 48 | 2 | PS50280 | |
| Domain | HMG_box | 8.20e-03 | 53 | 48 | 2 | PF00505 | |
| Domain | HMG | 8.50e-03 | 54 | 48 | 2 | SM00398 | |
| Domain | - | 8.81e-03 | 55 | 48 | 2 | 1.10.30.10 | |
| Domain | HMG_box_dom | 1.21e-02 | 65 | 48 | 2 | IPR009071 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.38e-04 | 277 | 41 | 6 | MM15414 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.45e-04 | 175 | 41 | 5 | MM14941 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.55e-04 | 283 | 41 | 6 | M13087 | |
| Pathway | REACTOME_MRNA_SPLICING | 2.77e-04 | 201 | 41 | 5 | MM15411 | |
| Pathway | REACTOME_MRNA_SPLICING | 3.54e-04 | 212 | 41 | 5 | M14033 | |
| Pathway | KEGG_SPLICEOSOME | 4.92e-04 | 127 | 41 | 4 | M2044 | |
| Pubmed | WBP11 ABI1 IRS4 CHERP PRCC FNBP4 SMARCC1 FMN2 ARHGAP35 SHTN1 SF3A2 SCAF4 CPSF7 | 1.83e-13 | 506 | 49 | 13 | 30890647 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 9.12e-13 | 154 | 49 | 9 | 16055720 | |
| Pubmed | MED15 KMT2D IRS4 UBAP2L RBM26 FNBP4 SMARCC1 WWTR1 ARHGAP35 SHTN1 SCAF4 | 2.33e-10 | 549 | 49 | 11 | 38280479 | |
| Pubmed | MED15 BCL9L WBP11 KMT2D IRS4 ZFHX4 PRCC UBAP2L SMARCC1 SMN1 RBM20 SCAF4 DHX30 CPSF7 | 6.42e-09 | 1429 | 49 | 14 | 35140242 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE4A KMT2D SETD1B MARVELD1 TULP4 PPRC1 MFN2 TBC1D25 ARHGAP35 KDM6B WNK2 DHX30 | 3.11e-08 | 1105 | 49 | 12 | 35748872 |
| Pubmed | 6.22e-08 | 251 | 49 | 7 | 31076518 | ||
| Pubmed | CASC3 WBP11 PDE4A ABI1 PRR36 UBAP2L SMARCC1 MFN2 GRM1 SHTN1 WNK2 | 7.72e-08 | 963 | 49 | 11 | 28671696 | |
| Pubmed | 9.72e-08 | 268 | 49 | 7 | 33640491 | ||
| Pubmed | 1.35e-07 | 425 | 49 | 8 | 24999758 | ||
| Pubmed | OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ. | 1.91e-07 | 91 | 49 | 5 | 30472188 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.35e-07 | 457 | 49 | 8 | 32344865 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GORASP2 IRS4 CHERP PRCC UBAP2L RBM26 ARHGAP35 SHTN1 SCAF4 DHX30 | 5.91e-07 | 934 | 49 | 10 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | WBP11 IRS4 CHERP PRCC UBAP2L RBM26 FNBP4 SMARCC1 SCAF4 CPSF7 | 7.17e-07 | 954 | 49 | 10 | 36373674 |
| Pubmed | 1.30e-06 | 57 | 49 | 4 | 18022353 | ||
| Pubmed | 1.41e-06 | 399 | 49 | 7 | 35987950 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.67e-06 | 807 | 49 | 9 | 22681889 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.69e-06 | 440 | 49 | 7 | 34244565 | |
| Pubmed | 2.86e-06 | 157 | 49 | 5 | 30186101 | ||
| Pubmed | 3.39e-06 | 653 | 49 | 8 | 33742100 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 4.93e-06 | 922 | 49 | 9 | 27609421 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 5.57e-06 | 180 | 49 | 5 | 35198878 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 8.33e-06 | 341 | 49 | 6 | 32971831 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 8.63e-06 | 197 | 49 | 5 | 22365833 | |
| Pubmed | 9.20e-06 | 347 | 49 | 6 | 16033648 | ||
| Pubmed | Neutrophils establish rapid and robust WAVE complex polarity in an actin-dependent fashion. | 1.16e-05 | 4 | 49 | 2 | 19200726 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 17664349 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 39337533 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.17e-05 | 774 | 49 | 8 | 15302935 | |
| Pubmed | 1.29e-05 | 560 | 49 | 7 | 35241646 | ||
| Pubmed | 1.47e-05 | 220 | 49 | 5 | 24550385 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.77e-05 | 1082 | 49 | 9 | 38697112 | |
| Pubmed | TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. | 1.94e-05 | 5 | 49 | 2 | 18568018 | |
| Pubmed | 2.06e-05 | 1103 | 49 | 9 | 34189442 | ||
| Pubmed | 2.14e-05 | 115 | 49 | 4 | 17332742 | ||
| Pubmed | 2.19e-05 | 608 | 49 | 7 | 16713569 | ||
| Pubmed | 2.26e-05 | 407 | 49 | 6 | 12693553 | ||
| Pubmed | 2.36e-05 | 615 | 49 | 7 | 31048545 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 21095589 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 8896557 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FNBP1 CASC3 TULP4 UBAP2L WASF3 FNBP4 ARHGAP35 KAT6B SHTN1 WNK2 | 3.58e-05 | 1489 | 49 | 10 | 28611215 |
| Pubmed | 3.75e-05 | 1497 | 49 | 10 | 31527615 | ||
| Pubmed | 3.79e-05 | 133 | 49 | 4 | 15144186 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 4.06e-05 | 272 | 49 | 5 | 25315684 | |
| Pubmed | 4.20e-05 | 274 | 49 | 5 | 34244482 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 4.59e-05 | 462 | 49 | 6 | 31138677 | |
| Pubmed | 4.63e-05 | 140 | 49 | 4 | 26930384 | ||
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 5.42e-05 | 8 | 49 | 2 | 23130995 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 22266653 | ||
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 6.20e-05 | 54 | 49 | 3 | 25631074 | |
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 22665483 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 8.49e-05 | 1024 | 49 | 8 | 24711643 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 10744724 | ||
| Pubmed | Identification and comparative analysis of hepatitis C virus-host cell protein interactions. | 1.06e-04 | 11 | 49 | 2 | 24136289 | |
| Pubmed | 1.11e-04 | 1371 | 49 | 9 | 36244648 | ||
| Pubmed | 1.27e-04 | 12 | 49 | 2 | 27563068 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 1.29e-04 | 69 | 49 | 3 | 28481362 | |
| Pubmed | 1.32e-04 | 809 | 49 | 7 | 32129710 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.35e-04 | 351 | 49 | 5 | 38297188 | |
| Pubmed | 1.50e-04 | 13 | 49 | 2 | 36395886 | ||
| Pubmed | 1.75e-04 | 14 | 49 | 2 | 32541010 | ||
| Pubmed | 1.75e-04 | 14 | 49 | 2 | 21795692 | ||
| Pubmed | 1.75e-04 | 14 | 49 | 2 | 8605874 | ||
| Pubmed | 1.75e-04 | 14 | 49 | 2 | 28174279 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 1.87e-04 | 1149 | 49 | 8 | 35446349 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.88e-04 | 857 | 49 | 7 | 25609649 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 1.94e-04 | 203 | 49 | 4 | 22083510 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.00e-04 | 605 | 49 | 6 | 28977666 | |
| Pubmed | 2.30e-04 | 16 | 49 | 2 | 20339383 | ||
| Pubmed | Ablation of Zfhx4 results in early postnatal lethality by disrupting the respiratory center in mice. | 2.30e-04 | 16 | 49 | 2 | 33475140 | |
| Pubmed | 2.30e-04 | 16 | 49 | 2 | 24368734 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.41e-04 | 398 | 49 | 5 | 35016035 | |
| Pubmed | 2.66e-04 | 638 | 49 | 6 | 31182584 | ||
| Pubmed | 2.81e-04 | 916 | 49 | 7 | 32203420 | ||
| Pubmed | Putative Protein Interactome of the Rhomboid Protease RHBDL4. | 2.93e-04 | 18 | 49 | 2 | 36857408 | |
| Pubmed | 3.02e-04 | 418 | 49 | 5 | 34709266 | ||
| Pubmed | 3.12e-04 | 421 | 49 | 5 | 34650049 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 3.64e-04 | 20 | 49 | 2 | 29785026 | |
| Pubmed | 3.64e-04 | 20 | 49 | 2 | 35177643 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 3.68e-04 | 678 | 49 | 6 | 30209976 | |
| Pubmed | 3.97e-04 | 245 | 49 | 4 | 35652658 | ||
| Pubmed | 3.98e-04 | 1285 | 49 | 8 | 35914814 | ||
| Pubmed | 4.00e-04 | 971 | 49 | 7 | 33306668 | ||
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 4.01e-04 | 21 | 49 | 2 | 27626377 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 4.17e-04 | 1294 | 49 | 8 | 30804502 | |
| Pubmed | 4.28e-04 | 451 | 49 | 5 | 36168627 | ||
| Pubmed | 4.36e-04 | 453 | 49 | 5 | 29656893 | ||
| Pubmed | Mammalian splicing factor SF1 interacts with SURP domains of U2 snRNP-associated proteins. | 4.41e-04 | 22 | 49 | 2 | 26420826 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 4.41e-04 | 22 | 49 | 2 | 26886794 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 4.46e-04 | 989 | 49 | 7 | 36424410 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 4.49e-04 | 704 | 49 | 6 | 32994395 | |
| Pubmed | 4.80e-04 | 713 | 49 | 6 | 29802200 | ||
| Pubmed | 4.83e-04 | 23 | 49 | 2 | 9225980 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 4.84e-04 | 714 | 49 | 6 | 28302793 | |
| Pubmed | 5.11e-04 | 469 | 49 | 5 | 27634302 | ||
| Pubmed | 5.26e-04 | 24 | 49 | 2 | 25176648 | ||
| Pubmed | 5.66e-04 | 114 | 49 | 3 | 31553912 | ||
| Pubmed | An inter-species protein-protein interaction network across vast evolutionary distance. | 5.83e-04 | 483 | 49 | 5 | 27107014 | |
| Pubmed | 6.28e-04 | 491 | 49 | 5 | 36273042 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 6.64e-04 | 497 | 49 | 5 | 36774506 | |
| Pubmed | 7.71e-04 | 29 | 49 | 2 | 36800290 | ||
| Interaction | ACTC1 interactions | WBP11 ABI1 IRS4 CHERP PRCC FNBP4 SMARCC1 FMN2 ARHGAP35 SHTN1 SF3A2 WNK2 SCAF4 CPSF7 | 6.41e-10 | 694 | 49 | 14 | int:ACTC1 |
| Interaction | SP7 interactions | BCL9L WBP11 KMT2D ZFHX4 PRCC SMARCC1 RBM20 SCAF4 DHX30 CPSF7 | 2.57e-09 | 304 | 49 | 10 | int:SP7 |
| Interaction | PRPF40A interactions | WBP11 ABI1 CHERP WASF3 FNBP4 SMARCC1 WWTR1 SF3A2 SCAF4 CPSF7 | 9.68e-08 | 446 | 49 | 10 | int:PRPF40A |
| Interaction | YAP1 interactions | MED15 BCL9L KMT2D IRS4 TULP4 UBAP2L RBM26 FNBP4 SMARCC1 WWTR1 ARHGAP35 SHTN1 SCAF4 CPSF7 | 2.03e-07 | 1095 | 49 | 14 | int:YAP1 |
| Interaction | WBP4 interactions | 2.52e-07 | 109 | 49 | 6 | int:WBP4 | |
| Interaction | EWSR1 interactions | MED15 BCL9L CASC3 WBP11 GORASP2 CHERP PRCC UBAP2L FNBP4 SMARCC1 SMN1 CPSF7 | 1.26e-06 | 906 | 49 | 12 | int:EWSR1 |
| Interaction | SNRNP40 interactions | BCL9L WBP11 CHERP PRPF40B PRCC SMARCC1 SF3A2 RBM20 SCAF4 CPSF7 | 2.50e-06 | 637 | 49 | 10 | int:SNRNP40 |
| Interaction | PRMT2 interactions | 2.74e-06 | 91 | 49 | 5 | int:PRMT2 | |
| Interaction | TLE3 interactions | 3.15e-06 | 376 | 49 | 8 | int:TLE3 | |
| Interaction | GATA3 interactions | 5.91e-06 | 187 | 49 | 6 | int:GATA3 | |
| Interaction | TOP3B interactions | GORASP2 PDE4A KMT2D SETD1B MARVELD1 TULP4 PPRC1 UBAP2L MFN2 TBC1D25 ARHGAP35 KDM6B WNK2 DHX30 | 6.76e-06 | 1470 | 49 | 14 | int:TOP3B |
| Interaction | APBB1 interactions | 7.52e-06 | 195 | 49 | 6 | int:APBB1 | |
| Interaction | NUP35 interactions | 7.61e-06 | 424 | 49 | 8 | int:NUP35 | |
| Interaction | SMC5 interactions | WBP11 IRS4 CHERP PRCC UBAP2L RBM26 FNBP4 SMARCC1 SMN1 SCAF4 CPSF7 | 2.18e-05 | 1000 | 49 | 11 | int:SMC5 |
| Interaction | CPSF6 interactions | 3.59e-05 | 526 | 49 | 8 | int:CPSF6 | |
| Interaction | NCK2 interactions | 3.99e-05 | 262 | 49 | 6 | int:NCK2 | |
| Interaction | SOX7 interactions | 4.69e-05 | 82 | 49 | 4 | int:SOX7 | |
| Interaction | TLX3 interactions | 7.14e-05 | 291 | 49 | 6 | int:TLX3 | |
| Interaction | LHX2 interactions | 8.06e-05 | 183 | 49 | 5 | int:LHX2 | |
| Interaction | FUBP1 interactions | 9.94e-05 | 309 | 49 | 6 | int:FUBP1 | |
| Interaction | NAA40 interactions | GORASP2 IRS4 CHERP PRCC UBAP2L RBM26 ARHGAP35 SHTN1 SCAF4 DHX30 | 1.01e-04 | 978 | 49 | 10 | int:NAA40 |
| Interaction | SNRNP70 interactions | CASC3 CHERP RBM26 SMARCC1 SMN1 ARHGAP35 SF3A2 SCAF4 DHX30 CPSF7 | 1.06e-04 | 984 | 49 | 10 | int:SNRNP70 |
| Interaction | KMT2A interactions | 1.09e-04 | 314 | 49 | 6 | int:KMT2A | |
| Interaction | JMJD6 interactions | 1.37e-04 | 205 | 49 | 5 | int:JMJD6 | |
| Interaction | TRIP10 interactions | 1.42e-04 | 109 | 49 | 4 | int:TRIP10 | |
| Interaction | TCERG1 interactions | 1.44e-04 | 207 | 49 | 5 | int:TCERG1 | |
| Interaction | MEN1 interactions | 1.53e-04 | 1029 | 49 | 10 | int:MEN1 | |
| Interaction | RCOR1 interactions | 1.80e-04 | 494 | 49 | 7 | int:RCOR1 | |
| Interaction | ITCH interactions | 2.15e-04 | 356 | 49 | 6 | int:ITCH | |
| Interaction | LUC7L interactions | 2.97e-04 | 242 | 49 | 5 | int:LUC7L | |
| Interaction | SRPK2 interactions | 3.06e-04 | 717 | 49 | 8 | int:SRPK2 | |
| Interaction | NXF1 interactions | FNBP1 CASC3 WBP11 UBAP2L RBM26 FNBP4 SMARCC1 MFN2 RBM20 DHX30 CPSF7 | 3.10e-04 | 1345 | 49 | 11 | int:NXF1 |
| Interaction | NEDD4 interactions | 3.23e-04 | 544 | 49 | 7 | int:NEDD4 | |
| Interaction | CFAP141 interactions | 3.24e-04 | 55 | 49 | 3 | int:CFAP141 | |
| Interaction | CRX interactions | 3.71e-04 | 254 | 49 | 5 | int:CRX | |
| Interaction | HOMER3 interactions | 3.71e-04 | 140 | 49 | 4 | int:HOMER3 | |
| Interaction | TNIP2 interactions | 4.21e-04 | 952 | 49 | 9 | int:TNIP2 | |
| Interaction | NCOA6 interactions | 4.24e-04 | 145 | 49 | 4 | int:NCOA6 | |
| Interaction | DAZL interactions | 4.24e-04 | 145 | 49 | 4 | int:DAZL | |
| Interaction | EP300 interactions | CASC3 WBP11 KMT2D PRCC RBM26 SMARCC1 WWTR1 SF3A2 SCAF4 DHX30 CPSF7 | 4.40e-04 | 1401 | 49 | 11 | int:EP300 |
| Interaction | GEMIN5 interactions | 4.66e-04 | 267 | 49 | 5 | int:GEMIN5 | |
| Interaction | ARHGAP12 interactions | 6.06e-04 | 68 | 49 | 3 | int:ARHGAP12 | |
| GeneFamily | RNA binding motif containing | 9.44e-07 | 213 | 29 | 6 | 725 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 7.28e-04 | 25 | 29 | 2 | 775 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.35e-03 | 34 | 29 | 2 | 487 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.98e-03 | 181 | 29 | 3 | 694 | |
| GeneFamily | PHD finger proteins | 9.12e-03 | 90 | 29 | 2 | 88 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_100 | 3.05e-06 | 100 | 48 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_500 | 1.59e-05 | 67 | 48 | 4 | gudmap_developingGonad_e12.5_ovary_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.00e-05 | 147 | 48 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_100 | 7.69e-05 | 100 | 48 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500_k-means-cluster#2 | 7.69e-05 | 100 | 48 | 4 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 9.78e-05 | 843 | 48 | 9 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 9.87e-05 | 844 | 48 | 9 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.04e-04 | 108 | 48 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500 | 1.17e-04 | 496 | 48 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#1_top-relative-expression-ranked_500 | 1.17e-04 | 42 | 48 | 3 | gudmap_developingGonad_e11.5_testes_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_500 | 1.54e-04 | 46 | 48 | 3 | gudmap_developingGonad_e12.5_epididymis_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 1.97e-04 | 50 | 48 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.12e-04 | 130 | 48 | 4 | gudmap_developingGonad_e12.5_ovary_k1_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_500_k-means-cluster#5 | 2.35e-04 | 53 | 48 | 3 | Facebase_RNAseq_e9.5_Olfactory Placode_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.53e-04 | 395 | 48 | 6 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_500 | 2.59e-04 | 137 | 48 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 4.23e-04 | 435 | 48 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | 4.28e-04 | 1259 | 48 | 10 | facebase_RNAseq_e9.5_MandArch_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500 | 4.34e-04 | 437 | 48 | 6 | gudmap_developingGonad_e11.5_testes_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | 4.40e-04 | 815 | 48 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_500 | 4.90e-04 | 68 | 48 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_500 | 5.79e-04 | 72 | 48 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | 5.81e-04 | 850 | 48 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_2500_k-means-cluster#2 | 6.54e-04 | 659 | 48 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_200 | 6.66e-04 | 17 | 48 | 2 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.97e-04 | 314 | 48 | 5 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#4 | 8.07e-04 | 683 | 48 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 8.60e-04 | 498 | 48 | 6 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_200 | 9.26e-04 | 20 | 48 | 2 | gudmap_developingGonad_e11.5_testes_k2_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.97e-04 | 196 | 48 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.11e-03 | 721 | 48 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#4 | 1.11e-03 | 90 | 48 | 3 | Facebase_RNAseq_e8.5_Floor Plate_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.19e-03 | 730 | 48 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.21e-03 | 732 | 48 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.22e-03 | 533 | 48 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.29e-03 | 210 | 48 | 4 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.31e-03 | 362 | 48 | 5 | gudmap_developingGonad_e18.5_testes_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.32e-03 | 743 | 48 | 7 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.33e-03 | 212 | 48 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_200 | 1.45e-03 | 25 | 48 | 2 | gudmap_developingGonad_e14.5_ epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 1.45e-03 | 25 | 48 | 2 | gudmap_developingGonad_e11.5_testes and mesonephros_k2_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_200 | 1.45e-03 | 25 | 48 | 2 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.46e-03 | 99 | 48 | 3 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_100 | 1.46e-03 | 99 | 48 | 3 | Facebase_RNAseq_e8.5_Floor Plate_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_100 | 1.50e-03 | 100 | 48 | 3 | Facebase_RNAseq_e10.5_Olfactory Pit_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 1.52e-03 | 986 | 48 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.55e-03 | 101 | 48 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.59e-03 | 378 | 48 | 5 | gudmap_developingGonad_e16.5_testes_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.73e-03 | 105 | 48 | 3 | gudmap_developingGonad_e18.5_epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.77e-03 | 229 | 48 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#4_top-relative-expression-ranked_200 | 1.82e-03 | 28 | 48 | 2 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k4_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 1.82e-03 | 231 | 48 | 4 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.08e-06 | 166 | 49 | 5 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 5.71e-05 | 192 | 49 | 5 | 6013_DN | |
| Drug | Indoprofen [31842-01-0]; Down 200; 14.2uM; PC3; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 4249_DN | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 6.00e-05 | 194 | 49 | 5 | 4662_DN | |
| Drug | Pentamidine isethionate [140-64-7]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 6.15e-05 | 195 | 49 | 5 | 4396_DN | |
| Drug | Hydroflumethiazide [135-09-1]; Down 200; 12uM; PC3; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 1809_DN | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 5285_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 6.45e-05 | 197 | 49 | 5 | 3209_UP | |
| Drug | AG-028671 [847803-03-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 6587_DN | |
| Drug | Dyclonine hydrochloride [536-43-6]; Down 200; 12.2uM; HL60; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 2392_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 6.61e-05 | 198 | 49 | 5 | 3418_DN | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 5321_DN | |
| Drug | Zalcitabine [7481-89-2]; Down 200; 19uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 4799_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 7172_UP | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 6.77e-05 | 199 | 49 | 5 | 1683_DN | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 3.37e-04 | 801 | 49 | 7 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQPMQPLLPQPPLPP | 161 | Q99218 | |
| SIAPPPPPMPQLTPQ | 361 | Q8IZP0 | |
| PPPMPQLTPQIPLTG | 366 | Q8IZP0 | |
| LPPPRLPPMCVNPTP | 21 | Q7L2E3 | |
| SGPRGMQQPPPPPQP | 36 | Q5T481 | |
| PPPLPPLQPSGMDAP | 381 | Q5T8P6 | |
| NRPPSALPLMGLPPP | 226 | Q8N684 | |
| PPNLTPPPMNLPPPL | 1881 | Q8WYB5 | |
| VAQPVPLLMTPPPPP | 326 | Q6ZVH7 | |
| LVNPGLPPLPSMPPR | 336 | Q9H8Y8 | |
| LPPLPSMPPRNLPGI | 341 | Q9H8Y8 | |
| QPLLPPPPCPAQPLG | 301 | Q9NYG8 | |
| GPMTPTQPPPPLSLP | 891 | O15054 | |
| PPPPPLAPPLIMENL | 536 | P29536 | |
| PPPPPVPHLQPMSQI | 321 | P27815 | |
| QSMPPPPQPSPQPGQ | 446 | Q96RN5 | |
| PIPLTPANPSMPPLP | 576 | O95140 | |
| PPPVSMSPGQPPPQQ | 601 | O15234 | |
| TMPPLPQPPLAPAAP | 81 | Q8IWX8 | |
| MSLLTSPHQPPPPPP | 331 | Q96RU3 | |
| LPPEDLPNQPPGPMP | 1261 | Q86UU0 | |
| MLPPPPRQPPPQARA | 1 | Q9BSK0 | |
| TPNPHMPQTPLPPRP | 876 | Q6UXX5 | |
| YPPPPPPQHLQMLPL | 1066 | Q13255 | |
| PLQGTEMLPPPPPPL | 901 | Q9NZ56 | |
| LPTPPFPPMAQPVIP | 371 | O95104 | |
| LGMPPSLPPPPLQPP | 886 | Q5VV67 | |
| QSKQQQMPPPPPPPP | 621 | O14654 | |
| LLNPRPYLLPPMPGP | 376 | Q5TCS8 | |
| LPPPPQMLAPAFPPP | 51 | Q92733 | |
| SLPPVPPMGLPPPQE | 596 | Q3MII6 | |
| PVLQPPLPLEMPPPP | 701 | Q8N3X1 | |
| PQQPPMTLPPLQPPL | 446 | A0PJY2 | |
| MTLPPLQPPLPTPGP | 451 | A0PJY2 | |
| PPLQVPPSPPASLPM | 986 | Q9H6K5 | |
| LPMSPLATPPPQAPP | 1041 | Q9H6K5 | |
| PLPPPPPNPIRSLMS | 361 | A0MZ66 | |
| NSFLPPPPPMPGPRL | 191 | Q16637 | |
| MLPLPLQPPLPPPRP | 1316 | Q9UPS6 | |
| SPPPTPQSPMQPLLP | 1476 | Q9NRY4 | |
| MPPPHPPQPGQIPGP | 1006 | Q92922 | |
| KRPPPPLMNGLPPRP | 231 | Q15428 | |
| PLMNGLPPRPPLPES | 236 | Q15428 | |
| PPLSLPPPPQGPMQL | 771 | Q9NRJ4 | |
| PLPPAPPQPSSMGPV | 1966 | Q86UP3 | |
| LPPGVPPLLPNPYIM | 791 | Q14157 | |
| PMAPPLAPLPPRDPN | 11 | Q9BV97 | |
| MALNRPQQPPPPPPP | 296 | Q9UPY6 | |
| LPPMSQRPPAIPPMP | 21 | Q6NWY9 | |
| QRPPAIPPMPPGILP | 26 | Q6NWY9 | |
| PPVSMSPAPQPPVLP | 401 | Q96NM4 | |
| PQPVLPPQPMLPPQP | 976 | Q9Y3S1 | |
| PPQPMLPPQPVLPPQ | 981 | Q9Y3S1 | |
| QIQAPPMPGPPPLGP | 401 | Q9Y2W2 | |
| MNPASAPPPLPPPGQ | 1 | Q9GZV5 | |
| SPQLMPPDPLPPPLS | 926 | O14686 |